ArticleDEN open2027
Crystal Violet Staining for Colitis-associated Neoplasia-guided Delineation of Ulcerative Colitis-associated Neoplasia for Endoscopic Submucosal Dissection: A Four-case Report.
Article in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ulcerative colitis-associated neoplasia (UCAN) is often difficult to delineate because chronic inflammatory changes obscure lesion borders. Accurate assessment of lesion extent is essential for curative endoscopic submucosal dissection (ESD), yet conventional white-light imaging frequently fails to clearly define lateral tumor spread. We report four patients with UCAN in whom crystal violet staining for colitis-associated neoplasia (CV-SCAN) was used to delineate lesion extent before ESD. All patients had ulcerative colitis in clinical remission and underwent surveillance colonoscopy. In these four patients, UCAN was identified as CV-neoplasia (CV-N) areas during CV-SCAN, whereas lesion borders remained indistinct on conventional white-light imaging. After histological confirmation by targeted biopsy, a repeat CV-SCAN was performed to determine lesion extent before ESD. In three patients, the CV-N-positive areas corresponded well with the pathological extent of neoplasia, and en bloc curative resection was achieved. One patient had a positive horizontal margin after the initial ESD. During an additional procedure, residual UCAN was again visualized as a CV-N-positive area and was successfully removed by additional ESD. No procedure-related adverse events or local recurrences were observed during follow-up. These cases suggest that CV-SCAN may facilitate delineation of UCAN before ESD and may help identify residual neoplasia that is difficult to recognize using white-light imaging alone. CV-SCAN should be considered an adjunctive technique that complements conventional endoscopic modalities rather than a standalone approach for lesion delineation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.